Vertically integrated, medical device contract manufacturing organization serving the medical device, diagnostics and drug delivery markets Cadence, Inc. announced on Thursday that it has named Bob White as a new director.
White brings more than 25 years of leadership experience in operational excellence, innovation, and strategic growth. White previously held senior roles at Medtronic, GE Healthcare and IBM, demonstrating expertise in managing global operations. As executive vice president and group president at Medtronic, he led 25,000 employees across 70 countries, overseeing five global businesses and driving above-market growth. White also executed seven acquisitions, a joint venture and a multi-billion-dollar divestiture. Currently, he serves as an Independent Director for Smith & Nephew and formerly held board positions at Mozarc Medical and CARE Hospitals. His background in medical device manufacturing and strategic insight will enhance Cadence's leadership team.
Matt Jennings, Cadence's chairman of the board, said, 'Bob will be an excellent addition to our board. His impressive track record in global business leadership and his commitment to innovation and growth will be instrumental as Cadence continues to advance its strategic goals and drive success, and he will be valuable to both the Board and Cadence's leadership team with their go-to market approach.'
Abbott launches new clinical trial to improve results in patients with advanced heart failure
United Therapeutics reaches milestone with 500th lung transplant via ex vivo lung perfusion service
Adocia patents stable hormone combinations for obesity and diabetes
GE HealthCare expands AI-enabled enterprise imaging with Blackford integration
Viatris reports positive results for EFFEXOR in GAD treatment in Japan
ALK secures U.S. FDA approval for AccuTest Allergy Skin Testing Devices
Conformal Medical reports start of GLACE study
Brain+ launches Ayla CST Assistant following UK regulatory approval
Accelerate Diagnostics receives FDA clearance for automated blood culture system
Photocure's partner Asieris presents Cevira Phase III subgroup analysis at 2024 CSCO Annual Meeting
Boston Scientific's FARAPULSE Pulsed Field Ablation system receives Japanese regulatory approval
Implantica advances RefluxStop with CE mark study results and prepares for FDA submission
Arrowhead Pharmaceuticals seeks approval for ARO-INHBE obesity study